234 results on '"Iwamura, Masatsugu"'
Search Results
2. Predictive Value of the Prostate-Specific Antigen Doubling Time for the Effectiveness of Metastasis-Directed Radiotherapy in Patients with Oligometastases after Radical Treatment for Non-metastatic Prostate Cancer: A Single Institution Retrospective Study
3. Real-world data on the comprehensive genetic profiling test for Japanese patients with metastatic castration-resistant prostate cancer
4. Membranous Expression of Heart Development Protein with EGF-like Domain 1 Is Associated with a Good Prognosis in Patients with Bladder Cancer
5. Expression of S100A16 Is Associated with Biological Aggressiveness and Poor Prognosis in Patients with Bladder Cancer Who Underwent Radical Cystectomy
6. Dosimetric Predictors of Toxicity after Prostate Stereotactic Body Radiotherapy: A Single-Institutional Experience of 145 Patients
7. Development and validation of a survival nomogram and calculator for male patients with metastatic castration-resistant prostate cancer treated with abiraterone acetate and/or enzalutamide
8. Local Therapy in Combination with Androgen Deprivation Therapy for Metastatic Prostate Cancer
9. Efficacy of Intravesical Instillation Therapy with Low-Dose Tokyo-172 Bacillus Calmette-Guérin to Prevent Recurrence of Non-Muscle-Invasive Bladder Cancer and Treat Carcinoma in situ: A Multi-Institutional Retrospective Study
10. Pre-Vaccination Anti-Severe Acute Respiratory Syndrome Coronavirus 2 Antibody Seroprevalence in Workers at Three Japanese Hospitals
11. The development and validation of a nomogram and calculator for survival among men treated with abiraterone acetate and/or enzalutamide for metastatic castration-resistant prostate cancer
12. Gemcitabine–Paclitaxel Chemotherapy for Patients with Advanced Urothelial Cancer Refractory to Cisplatin-Based Chemotherapy: Predictive Role of PGK1 for Treatment Response to Cytotoxic Chemotherapy
13. Outcomes of artificial urinary sphincter implantation in patients with diabetes mellitus: A subgroup analysis
14. Diagnostic Potential of Circulating Tumor Cells, Urinary MicroRNA, and Urinary Cell-Free DNA for Bladder Cancer: A Review
15. Noninferior oncological outcomes in adults aged 80 years or older compared with younger patients who underwent radical nephroureterectomy for upper tract urothelial carcinoma
16. Real‐world treatment patterns and oncological outcomes in early relapse and refractory disease after bacillus Calmette‐Guérin failure in non‐muscle‐invasive bladder cancer
17. Decreased GM3 correlates with proteinuria in minimal change nephrotic syndrome and focal segmental glomerulosclerosis
18. DJ-1 Expression Might Serve as a Biologic Marker in Patients with Bladder Cancer
19. Impact of salvage cytotoxic chemotherapy on prognosis in patients with recurrence after radical cystectomy: a multi-institutional retrospective study
20. MP03-11 HIGH EXPRESSION OF AHNAK2 IS ASSOCIATED WITH BIOLOGICALLY AGGRESSIVE FINDINGS AND POOR SURVIVAL IN PATIENTS TREATED WITH RADICAL CYSTECTOMY
21. A multi‐institutional retrospective study of open versus laparoscopic nephroureterectomy focused on the intravesical recurrence
22. Patients with Non-Muscle Invasive Bladder Cancer Previously Treated with Nephroureterectomy Have a High Risk of Recurrence after Bacillus Calmette-Guérin Intravesical Instillation Therapy
23. Expression of Membranous CD155 Is Associated with Aggressive Phenotypes and a Poor Prognosis in Patients with Bladder Cancer
24. Dynamics of Cancer-Related Proteins in Patients with Bladder Cancer
25. Impact of Salvage Cytotoxic Chemotherapy on Prognosis in Patients with Recurrence After Radical Cystectomy: A Multi-Institutional Retrospective Study
26. Serum Epiplakin Might Be a Potential Serodiagnostic Biomarker for Bladder Cancer
27. Effect of cisplatin on metastatic castration-resistant prostate cancer with BRCA2 mutation: A case report
28. Cytopathic effects and local immune responses in repeated neoadjuvant HSV-tk + ganciclovir gene therapy for prostate cancer
29. Prognostic Impact of AHNAK2 Expression in Patients Treated with Radical Cystectomy
30. High HNRNPA3 expression is associated with lymph node metastasis and poor prognosis in patients treated with radical cystectomy
31. PD-L1 expression in tumor-infiltrating lymphocytes (TILs) as an independent predictor of prognosis in patients with pN0 bladder cancer undergoing radical cystectomy
32. Signaling Pathways and Biomarkers in Renal Tumors
33. Impact of maintenance therapy using a half dose of the bacillus Calmette–Guérin Tokyo strain on recurrence of intermediate and high-risk nonmuscle invasive bladder cancer: a retrospective single-center study
34. Prognostic Impact of Perirenal Fat or Adrenal Gland Involvement in Renal Cell Carcinoma Exhibiting Venous Vascular Extension
35. Oncologic Outcomes of Salvage Chemotherapy in Patients with Recurrent or Metastatic Lesions after Radical Nephroureterectomy: A Multi-Institutional Retrospective Study
36. Complete biochemical response following metastasis-directed radiotherapy for oligometastatic prostate cancer: A case report
37. The development and validation of a prognostic nomogram and nomogram application software among men treated with abiraterone acetate and/or enzalutamide for metastatic castration-resistant prostate cancer
38. A high neutrophil-to-lymphocyte ratio is a poor prognostic factor for castration-resistant prostate cancer patients who undergo abiraterone acetate or enzalutamide treatment
39. A novel prognostic model for Japanese patients with newly diagnosed bone‐metastatic hormone‐naïve prostate cancer
40. The Development and Validation of a Prognostic Nomogram and Nomogram Application Software Among Men Treated with Abiraterone Acetate and/or Enzalutamide for Metastatic Castration-resistant Prostate Cancer
41. Prognostic impact of preoperative renal function in patients treated with radical cystectomy: a multi-institutional retrospective study
42. Prognostic Value of the LATITUDE and CHAARTED Risk Criteria for Predicting the Survival of Men with Bone Metastatic Hormone-Naïve Prostate Cancer Treated with Combined Androgen Blockade Therapy: Real-World Data from a Japanese Multi-Institutional Study
43. Size of pelvic bone metastasis as a significant prognostic factor for metastatic prostate cancer patients
44. The Interaction of Urinary Components with Biomaterials in the Urinary Tract: Ureteral Stent Discoloration
45. Electronic nose to distinguish bladder cancer by urinary odour feature: A pilot study
46. Microsomal prostaglandin E synthase-1 promotes lung metastasis via SDF-1/CXCR4-mediated recruitment of CD11b+Gr1+MDSCs from bone marrow
47. Laparoscopic adrenalectomy by the posterior lumbar approach
48. Outcome of third‑line sunitinib after sequential therapy with cytokines and sorafenib in metastatic renal cell carcinoma
49. A phase I dose-escalation trial of stereotactic body radiotherapy using 4 fractions for patients with localized prostate cancer
50. Size of pelvic bone metastasis as a significant prognostic factor for metastatic prostate cancer patients
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.